Late-onset X-linked adrenal hypoplasia (DAX-1, NR0B1): two new adult-onset cases from a single center.

Abstract:

PURPOSE:DAX-1 (NR0B1) is an orphan nuclear receptor, which plays a critical role in development and regulation of the adrenal gland and hypothalamo-pituitary-gonadal axis. Mutations in NR0B1 lead to adrenal hypoplasia congenita (AHC), hypogonadotropic hypogonadism (HH) and azoospermia in men. Presentation is typically with adrenal insufficiency (AI) during infancy or childhood. To date only eight cases/kindreds are reported to have presented in adulthood. METHODS:We describe two new cases of men with DAX-1 mutations who presented in adulthood and who were diagnosed at a large University Hospital. RESULTS:Case 1 presented with AI at 19 years. At 38 years he was diagnosed with HH. Detailed history revealed a brother diagnosed with AI at a similar age. Sequencing of the DAX-1 (NR0B1) gene revealed a heterozygous c.775T > C substitution in exon 1, which changes codon 259 from serine to proline (p.Ser259Pro). Case 2 was diagnosed with AI at 30 years. Aged 37 years he presented with HH and azoospermia. He was treated with gonadotropin therapy but remained azoospermic. Testicular biopsy showed maturational arrest and hypospermatogenesis. Analysis of the NR0B1 gene showed a heterozygous c.836C > T substitution in exon 1, resulting in a change of codon 279 from proline to leucine (p.Pro279Leu). This change alters the structure of the repression helix domain of DAX-1 and affects protein complex interactions with NR5A family members. CONCLUSIONS:We describe two missense mutations within the putative carboxyl-terminal ligand binding domain of DAX-1, presenting with AHC and HH in adulthood, from a single center. DAX-1 mutations may be more frequent in adults than previously recognized. We recommend testing for DAX-1 mutations in all adults with primary AI and HH or impaired fertility where the etiology is unclear.

journal_name

Pituitary

journal_title

Pituitary

authors

Kyriakakis N,Shonibare T,Kyaw-Tun J,Lynch J,Lagos CF,Achermann JC,Murray RD

doi

10.1007/s11102-017-0822-x

subject

Has Abstract

pub_date

2017-10-01 00:00:00

pages

585-593

issue

5

eissn

1386-341X

issn

1573-7403

pii

10.1007/s11102-017-0822-x

journal_volume

20

pub_type

杂志文章
  • Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.

    abstract::A high incidence of venous thromboembolic (VTE) complications has been reported in Cushing's syndrome (CS), mostly post-operatively and attributable to hypercoagulability. The prevalence of symptomatic VTE was investigated retrospectively in 58 consecutive CS patients in relation to acquired and genetic thrombotic ris...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0398-4

    authors: Koutroumpi S,Daidone V,Sartori MT,Cattini MG,Albiger NM,Occhi G,Ferasin S,Frigo A,Mantero F,Casonato A,Scaroni C

    更新日期:2013-06-01 00:00:00

  • Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline.

    abstract:OBJECTIVE:The purpose of this study was to define safety and efficacy of medical therapy in the treatment of nonfunctioning pituitary tumours. DESIGN:We studied thirteen patients with a clinically nonfunctioning pituitary macroadenoma for response to cabergoline treatment for 1 year. Twelve/13 patients were already op...

    journal_title:Pituitary

    pub_type: 临床试验,杂志文章

    doi:10.1023/a:1015366923810

    authors: Lohmann T,Trantakis C,Biesold M,Prothmann S,Guenzel S,Schober R,Paschke R

    更新日期:2001-08-01 00:00:00

  • A prospective longitudinal study of Pasireotide in Nelson's syndrome.

    abstract:PURPOSE:Nelson's syndrome is a challenging condition that can develop following bilateral adrenalectomy for Cushing's disease, with high circulating ACTH levels, pigmentation and an invasive pituitary tumor. There is no established medical therapy. The aim of the study was to assess the effects of pasireotide on plasma...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0853-3

    authors: Daniel E,Debono M,Caunt S,Girio-Fragkoulakis C,Walters SJ,Akker SA,Grossman AB,Trainer PJ,Newell-Price J

    更新日期:2018-06-01 00:00:00

  • Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma.

    abstract::In this report we emphasize the opportunity of considering the uncommon causes of chronic GH-excess in the initial diagnostic process, such as GHRH hypersecretion, especially in the presence of ambiguous pituitary neuroimaging. This topic may have an important clinical significance in order to plan the most cost-effec...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-008-0146-y

    authors: Verrua E,Ronchi CL,Ferrante E,Ferrari DI,Bergamaschi S,Ferrero S,Zatelli MC,Branca V,Spada A,Beck-Peccoz P,Lania AG

    更新日期:2010-09-01 00:00:00

  • Pathology of prolactinomas: any predictive value?

    abstract::Lactotroph adenomas, also called prolactinomas and prolactin-secreting adenomas, constitute nearly 80% of functioning pituitary tumors and about 30-50% of all adenomas in the clinical practice. Lactotroph adenomas occur in the general population at a prevalence of 45/100,000, are more common in women, but also involve...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-019-00997-1

    authors: Lopes MBS

    更新日期:2020-02-01 00:00:00

  • What are critical outcome measures for patients receiving pituitary replacement following brain injury?

    abstract::There are scant prospective studies defining improvements in critical outcome measures with hormone replacement in hypopituitarism secondary to brain injury. We review the tests of cognition and physical function and summarize their use for subjects that are deficient in anterior hormone production during anterior pit...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0133-3

    authors: Beca SG,High WM Jr,Masel BE,Mossberg KA,Urban RJ

    更新日期:2012-03-01 00:00:00

  • MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study.

    abstract::MAP-2, a well characterized member of the microtubule associated protein (MAP) family, binds to and stabilizes microtubules and is involved in cell proliferation as well as neuronal differentiation. The aim of the present work was to study MAP-2 expression in human adenohypophyses and pituitary adenomas. To our knowle...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-1523-4

    authors: Rotondo F,Oniya K,Kovacs K,Bell CD,Scheithauer BW

    更新日期:2005-01-01 00:00:00

  • Importance of cannulated prolactin test in the definition of hyperprolactinaemia.

    abstract:PURPOSE:Recent guidelines suggest that a single prolactin measurement is adequate to confirm hyperprolactinaemia. This may lead to unnecessary investigation of artefactual hyperprolactinaemia. Prolactin measurement drawn from an indwelling cannula after rest removes stress as a confounding variable. The objective was t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-014-0576-7

    authors: Whyte MB,Pramodh S,Srikugan L,Gilbert JA,Miell JP,Sherwood RA,McGregor AM,Aylwin SJ

    更新日期:2015-06-01 00:00:00

  • Medical combination therapies in Cushing's disease.

    abstract:INTRODUCTION:There has been growing interest on medical therapy for the management of Cushing's disease (CD), particularly in cases of persistent or recurrent hypercortisolism. Ketoconazole, an inhibitor of adrenal steroidogenesis, is the most widely used drug, whereas cabergoline and pasireotide are the most promising...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-015-0641-x

    authors: Vilar L,Naves LA,Machado MC,Bronstein MD

    更新日期:2015-04-01 00:00:00

  • Geometric survey on magnetic resonance imaging of growth hormone producing pituitary adenoma.

    abstract::Apart from the radiologic features regarding size and invasiveness, we had noticed some differences in morphology among types of pituitary adenomas. We conducted this study to verify the differences in radiologic morphology between growth hormone producing pituitary adenomas (GHoma) and nonfunctioning pituitary adenom...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0479-z

    authors: Bakhtiar Y,Hanaya R,Tokimura H,Hirano H,Oyoshi T,Fujio S,Bohara M,Arita K

    更新日期:2014-04-01 00:00:00

  • Suprasellar granular cell tumor of the neurohypophysis: surgical outcome of a very rare tumor.

    abstract:PURPOSE:Granular cell tumors of the neurohypophysis are rare, solitary lesions, mostly presenting in the adult age. They rarely grow to a sufficient size to cause mass effect related symptoms and they may be found in most cases incidentally at autopsy. Because of their rarity as of now they have been described only as ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0704-7

    authors: Gagliardi F,Spina A,Barzaghi LR,Bailo M,Losa M,Terreni MR,Mortini P

    更新日期:2016-06-01 00:00:00

  • Combined treatment of invasive giant prolactinomas.

    abstract::The management of invasive giant prolactinomas (IGP) has been an area of some controversy. The relative roles of transsphenoidal surgery, craniotomy, radiation therapy and dopamine agonist based medical therapy are gradually becoming clarified. We report the results of management of 30 patients with IGP. Surgery was t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-5087-0

    authors: Yu C,Wu Z,Gong J

    更新日期:2005-01-01 00:00:00

  • Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.

    abstract:INTRODUCTION:Temozolomide (TMZ) is an oral alkylating agent that has been used over the past 8 years to treat aggressive pituitary tumors resistant to conventional therapy. To date, only 25 patients treated with TMZ for ACTH producing pituitary tumors (14 adenomas and 11 carcinomas) have been reported. MATERIALS AND M...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-015-0694-x

    authors: Campderá M,Palacios N,Aller J,Magallón R,Martín P,Saucedo G,Lilienfeld H,Estrada J

    更新日期:2016-04-01 00:00:00

  • Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging.

    abstract::The availability of various first-line treatment modalities for acromegaly and evolving surgical techniques emphasize the need for accurately defined predictors of surgical outcome. We retrospectively analysed the outcome of 30 patients with acromegaly after initial endoscopic transsphenoidal surgery in two university...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0395-7

    authors: van Bunderen CC,van Varsseveld NC,Baayen JC,van Furth WR,Aliaga ES,Hazewinkel MJ,Majoie CB,Freling NJ,Lips P,Fliers E,Bisschop PH,Drent ML

    更新日期:2013-06-01 00:00:00

  • Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center.

    abstract:PURPOSE:Long-acting somatostatin analogs are one of the main classes of medical therapy used for acromegaly and most patients require ongoing treatment. Few studies have evaluated the long-term efficacy and safety of lanreotide depot beyond 2 years. The goal of this study was to provide a long-term longitudinal assessm...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0724-3

    authors: Sagvand BT,Khairi S,Haghshenas A,Swearingen B,Tritos NA,Miller KK,Klibanski A,Nachtigall LB

    更新日期:2016-08-01 00:00:00

  • Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.

    abstract:PURPOSE:Endogenous Cushing's syndrome (CS) is a rare disease that results from exposure to high levels of cortisol; Cushing's disease (CD) is the most frequent form of CS. Patients with CS suffer from a variety of comorbidities that increase the risk of mortality. Surgical resection of the disease-causing lesion is gen...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-016-0742-1

    authors: Fleseriu M,Castinetti F

    更新日期:2016-12-01 00:00:00

  • Proliferation markers in different types of clinically non-secreting pituitary adenomas.

    abstract::160 clinically non-secreting pituitary adenomas were examined in regard to their expression of the markers PCNA, bcl2, Ki 67 in the mib-1 modification and p53 which are still under investigation for their relevance to cell proliferation. The series contained 60 null cell adenomas, 60 oncocytomas and 40 gonadotroph ade...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009933820856

    authors: Schreiber S,Saeger W,Lüdecke DK

    更新日期:1999-05-01 00:00:00

  • Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas.

    abstract::We evaluated the efficacy of Gamma knife stereotactic radiosurgery (GKSR) as an adjunctive management modality for patients with drug resistant or intolerant cavernous sinus invasive prolactinomas. Twenty-two patients with cavernous sinus invasive prolactinoma underwent GKSR between 1994 and 2009. Thirteen patients we...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0376-x

    authors: Liu X,Kano H,Kondziolka D,Park KJ,Iyer A,Shin S,Niranjan A,Flickinger JC,Lunsford LD

    更新日期:2013-03-01 00:00:00

  • Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

    abstract:PURPOSE:Patients treated for pituitary adenomas generally report a reduced quality of life (QoL). At present, the patient's perspective of QoL has not been fully addressed and this, and further insight in potential determinants of QoL in pituitary diseases is required to design strategies to improve QoL. We aimed to de...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-014-0561-1

    authors: Andela CD,Niemeijer ND,Scharloo M,Tiemensma J,Kanagasabapathy S,Pereira AM,Kamminga NG,Kaptein AA,Biermasz NR

    更新日期:2015-02-01 00:00:00

  • Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.

    abstract:BACKGROUND:Xanthogranulomas are inflammatory masses most commonly found at peripheral sites such as the skin. Sellar and parasellar xanthogranulomas are rare and present a diagnostic challenge as they are difficult to differentiate from other sellar lesions such as craniopharyngiomas and Rathke's cleft cysts pre-operat...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0859-x

    authors: Ved R,Logier N,Leach P,Davies JS,Hayhurst C

    更新日期:2018-06-01 00:00:00

  • Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease.

    abstract::A 54-years-old woman diagnosed of myotonic dystrophy (MyD) with past medical history of massive postpartum haemorrhage at age 28 and panhypopituitarism was studied. BMI and body composition were determined and we determined baseline serum IGF-I, IGFBP3, insulin and leptin levels and after the IGF-I generation test per...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009984505312

    authors: Gómez JM,Martínez-Matos JA

    更新日期:1999-01-01 00:00:00

  • Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study.

    abstract::Surgical cure cannot be achieved in most patients with invasive non-functioning pituitary macroadenoma (NFPA). Short-term residual tumor treatment with somatostatin analogs has produced disappointing results. This prospective case-control study assessed the efficacy of chronic treatment with long acting octreotide (oc...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0370-8

    authors: Fusco A,Giampietro A,Bianchi A,Cimino V,Lugli F,Piacentini S,Lorusso M,Tofani A,Perotti G,Lauriola L,Anile C,Maira G,Pontecorvi A,De Marinis L

    更新日期:2012-12-01 00:00:00

  • Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview.

    abstract:BACKGROUND:The growing interest in the molecular and genetic alterations of craniopharyngiomas (CPs) is embodied in recent studies revealing insights into the CP tumorigenesis and identifying novel molecular pathways amenable of targeted therapies. The actual impact of this new information, however, remains inconclusiv...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-018-0890-6

    authors: Prieto R,Pascual JM

    更新日期:2018-08-01 00:00:00

  • Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.

    abstract:INTRODUCTION:Autoimmune lymphocytic hypophysitis associates predominantly with other autoimmune endocrinopathies and is most commonly treated with glucocorticoids and/or decompressive pituitary surgery. Here we report a new association and treatment modality for lymphocytic hypophysitis. METHODS:A 52-year-old woman pr...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-014-0592-7

    authors: Xu C,Ricciuti A,Caturegli P,Keene CD,Kargi AY

    更新日期:2015-08-01 00:00:00

  • Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population.

    abstract::GH and IGF-1 play an important role in the regulation of metabolism and body composition. In patients with uncontrolled acromegaly, cardiovascular morbidity and mortality are increased but are supposed to be normalised after biochemical control is achieved. We aimed at comparing body composition and the cardiovascular...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-010-0218-7

    authors: Dimopoulou C,Sievers C,Wittchen HU,Pieper L,Klotsche J,Roemmler J,Schopohl J,Schneider HJ,Stalla GK

    更新日期:2010-09-01 00:00:00

  • Overview of vascular complications of pituitary surgery with special emphasis on unexpected abnormality.

    abstract::Arterial bleeding during transsphenoidal surgery for pituitary adenoma is known complication. This usually happens due to rupture of intracavernous carotid or delayed hemorrhage due to the carotico-cavernous fistula and/or pseudoaneurysm. There is also evidence that cavernous carotid aneurysms may occur with pituitary...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-009-0198-7

    authors: Berker M,Aghayev K,Saatci I,Palaoğlu S,Onerci M

    更新日期:2010-06-01 00:00:00

  • The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

    abstract::The metabolic consequences of thyroxine replacement in patients with central hypothyroidism (CH) need to be evaluated. The aim was to examine the outcome of thyroxine replacement in CH. Adult hypopituitary patients (n = 1595) with and without CH from KIMS (Pfizer International Metabolic Database) were studied before a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0356-6

    authors: Filipsson Nyström H,Feldt-Rasmussen U,Kourides I,Popovic V,Koltowska-Häggström M,Jonsson B,Johannsson G

    更新日期:2012-12-01 00:00:00

  • Traumatic brain injury induced neuroendocrine changes: acute hormonal changes of anterior pituitary function.

    abstract:PURPOSE:It is estimated that approximately 69 million individuals worldwide will sustain a TBI each year, which accounts for substantial morbidity and mortality in both children and adults. TBI may lead to significant neuroendocrine changes, if the delicate pituitary is ruptured. In this review, we focus on the anterio...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-019-00944-0

    authors: Ntali G,Tsagarakis S

    更新日期:2019-06-01 00:00:00

  • Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature.

    abstract::Pituitary adenomas rarely originate outside the sella turcica. Ectopic locations include the suprasellar region, sphenoid sinus, cavernous sinus and clivus. We describe a 50-year-old female who presented with clinical signs and biochemical evidence of acromegaly. Pituitary MRI demonstrated a 2 mm hypointense lesion on...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-011-0345-9

    authors: Appel JG,Bergsneider M,Vinters H,Salamon N,Wang MB,Heaney AP

    更新日期:2012-12-01 00:00:00

  • Management of cystic prolactinomas: a review.

    abstract:INTRODUCTION:Cystic prolactinoma is a variant of prolactin-secreting pituitary adenoma. The strategies for the management of cystic prolactinoma have not been addressed thoroughly in clinical guidelines. METHODS:A literature search was performed using Pubmed to review the current approaches to the treatment of cystic ...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-018-0888-0

    authors: Nakhleh A,Shehadeh N,Hochberg I,Zloczower M,Zolotov S,Taher R,Daoud Naccache D

    更新日期:2018-08-01 00:00:00